Provided by Tiger Trade Technology Pte. Ltd.

Artiva Biotherapeutics, Inc.

10.24
-0.1850-1.78%
Volume:141.80K
Turnover:1.46M
Market Cap:500.35M
PE:-3.19
High:10.61
Open:10.49
Low:10.10
Close:10.42
52wk High:14.53
52wk Low:2.22
Shares:48.89M
Float Shares:19.28M
Volume Ratio:0.53
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2084
EPS(LYR):-3.4309
ROE:-36.58%
ROA:-22.34%
PB:1.44
PE(LYR):-2.98

Loading ...

Major Investor Doubles Down on Artiva Biotherapeutics With Bold New Move

TIPRANKS
·
Jul 29

RA Capital Management Reports USD 412,776 Artiva Biotherapeutics Common Share Purchase

Reuters
·
Jul 29

RA Capital Management Acquires USD 2.62 Million of Artiva Biotherapeutics Common Shares

Reuters
·
Jul 24

Artiva Biotherapeutics Sets Deadline for 2026 Meeting

TIPRANKS
·
Jul 23

Artiva Biotherapeutics Announces 2026 Annual Shareholder Meeting

Reuters
·
Jul 23

Major Insider Move Signals Growing Confidence in Artiva Biotherapeutics

TIPRANKS
·
Jul 21

RA Capital Management Reports $1.43 Million Purchase of Artiva Biotherapeutics Shares

Reuters
·
Jul 21

Artiva Biotherapeutics Issues 288,800 Rsus to 17 New Hires Under Inducement Plan

Reuters
·
Jul 17

Artiva Biotherapeutics Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 17

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 17

RA Capital Management Reports Purchase of Artiva Biotherapeutics Common Shares Worth $194,237.66

Reuters
·
Jul 15

Major Stake Boost Signals Growing Confidence in Artiva Biotherapeutics

TIPRANKS
·
Jun 30

RA Capital Management Reports $292,129 Artiva Biotherapeutics Common Share Purchase

Reuters
·
Jun 30

Artiva Biotherapeutics to join H.C. Wainwright Cell Therapy Virtual Conference fireside chat

Reuters
·
Jun 24

RA Capital Management reports USD 4.56 million Artiva Biotherapeutics common stock acquisition

Reuters
·
Jun 17

RA Capital Management acquires Artiva Biotherapeutics common shares worth $8.19 million

Reuters
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV), MoonLake Immunotherapeutics (MLTX) and MBX Biosciences, Inc. (MBX)

TIPRANKS
·
Jun 09

Artiva Biotherapeutics Price Target Maintained With a $41.00/Share by Needham

Dow Jones
·
Jun 08

Needham Sticks to Its Buy Rating for Artiva Biotherapeutics, Inc. (ARTV)

TIPRANKS
·
Jun 08

Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026

TIPRANKS
·
Jun 08